Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Autologous Stem Cell Transplantation × plerixafor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 29 Lymphoma, Non-Hodgkin 27 Leukemia, Myeloid, Acute 21 Hodgkin Disease 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 10 Leukemia, Lymphocytic, Chronic, B-Cell 9 Lymphoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8 Leukemia 5 Pancreatic Neoplasms 3 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Follicular 3 Hematologic Neoplasms 3 Gliosarcoma 3 Glioblastoma 3 Warts 2 Sezary Syndrome 2 Neutropenia 2 Myeloproliferative Disorders 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Hairy Cell 2 Infections 2 Immunologic Deficiency Syndromes 2 Glioma 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02006225 2013-12-10

GCSF

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown

Autologous Stem Cell Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡